Regulation of plasminogen activator inhibitor-1 and urokinase by hyaluronan fragments in mouse macrophages

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 279, Issue 4 23-4, 2000, Pages

  Horton, Maureen R ^a   Olman, Mitchell A ^b   Bao, Clare ^a   White, Kimberly E ^b   Choi, Augustine M K ^c,d   Chin, Beek Yok ^c,d   Noble, Paul W ^c,d   Lowenstein, Charles J ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

Author keywords

Chronic fibrosis; Extracellular matrix; Lung

Indexed keywords

HYALURONIC ACID; PLASMINOGEN ACTIVATOR INHIBITOR 1; UROKINASE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME REGULATION; EXTRACELLULAR MATRIX; LUNG ALVEOLUS MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0033697108     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.2000.279.4.l707     Document Type: Article

References (62)

1. Hyaluronic acid in synovial fluid. I. Molecular parameters of hyaluronic acid in normal and arthritic human fluids
2. Plasminogen activator inhibitor-1 in acute hyperoxic mouse lung injury
3. Depressed bronchoalveolar urokinase activity in patients with adult respiratory distress syndrome
4. Mechanisms of pulmonary fibrosis: Spontaneous release of the alveolar macrophage-derived growth factor in the interstitial lung disorders
5. Urokinase-dependent cell surface proteolysis and cancer
6. Immunoprecipitation
7. Unraveling pulmonary fibrosis: The bleomycin model
8. Plasminogen activator inhibitor-1 gene-deficient mice. II. Effects on hemostasis, thrombosis, and thrombolysis
9. Developmental expression of plasminogen activator inhibitor type i by human alveolar macrophages. Possible role in lung injury
10. Cryptic chemotactic activity of fibronectin for human monocytes resides in the 120-kDa fibroblastic cell-binding fragment
11. Generation in plasma of a fast-acting inhibitor of plasminogen activator in response to endotoxin stimulation
12. Plasminogen activators, tissue degradation, and cancer
13. The murine urokinase-type plasminogen activator gene
14. The plasminogen activator inhibitor- 2 is not required for normal murine development or survival
15. Bleomycin-induced pulmonary fibrosis in transgenic mice that either lack or overexpress the murine plasminogen activator inhibitor-1 gene
16. Reverse fibrin autography: A method to detect and partially characterize protease inhibitors after sodium dodecyl sulfate-polyacrylamide gel electrophoresis
17. Identification of newly transcribed R.N.A.
18. Rat alveolar epithelial cells concomitantly express plasminogen activator inhibitor- 1 and urokinase
19. Urokinase expression in mononuclear phagocytes: Cytokine-specific modulation by interferon-gamma and tumor necrosis factor-alpha
20. Hyaluronate in bronchoalveolar lavage fluid: A new marker in sarcoidosis reflecting pulmonary disease
21. The connective tissue of lung
22. Induction of IL-12 and chemokines by hyaluronan requires adhesion-dependent priming of resident but not elicited macrophages
23. Regulation of hyaluronan-induced chemokine gene expression by IL-10 and IFN-γ in mouse macrophages
24. Hyaluronan fragments synergize with interferon-gamma to induce the C-X-C chemokines mig and interferon-inducible protein-10 in mouse macrophages
25. Induction and regulation of macrophage metalloelastase by hyaluronan fragments in mouse macrophages
26. Local abnormalities in coagulation and fibrinolytic pathways predispose to alveolar fibrin deposition in the adult respiratory distress syndrome
27. Serial abnormalities of fibrin turnover in evolving adult respiratory distress syndrome
28. SignaI transduction from the extracellular matrix
29. Hyaluronate-enhanced hematopoiesis: Two different receptors trigger the release of interleukin-1beta and interleukin- 6 from bone marrow macrophages
30. Macrophage production of transforming growth factor beta and fibroblast collagen synthesis in chronic pulmonary inflammation
31. Role of laminin in matrix induction of macrophage urokinase-type plasminogen activator and 92-kDa metalloproteinase expression
32. Biological and clinical aspects of plasminogen activator inhibitor type 2
33. Modulation of the plasminogen activation system in murine macrophages
34. Activation of alveolar macrophages by native and synthetic collagen-like polypeptides
35. Hyaluronan
36. Mechanisms of murine RANTES chemokine gene induction by Newcastle disease virus
37. Type 1 plasminogen activator inhibitor
38. Expression of urokinase-type plasminogen activator, its receptor and type- 1 plasminogen activator inhibitor is differently regulated by inhibitors of protein synthesis in human cancer cell lines
39. Exaggerated spontaneous release of platelet-derived growth factor by alveolar macrophages from patients with idiopathic pulmonary fibrosis
40. MH-S, a murine alveolar macrophage cell line: Morphological, cytochemical, and functional characteristics
41. Hyaluronan fragments induce nitric oxide in murine macrophages through an NF-κB-dependent mechanism
42. Hyaluronan (HA) fragments induce chemokine gene expression in alveolar macrophages. The role of HA size and CD 44
43. Synergistic effect of hyaluronan oligosaccharides and vascular endothelial growth factor on angiogenesis in vitro
44. Hyaluronan (hyaluronic acid) in bronchoalveolar lavage fluid during the development of bleomycin-induced alveohtis in the rat
45. Alveolar accumulation of hyaluronan and alveolar cellular response in bleomycin-induced alveolitis
46. Hyaluronate activation of CD44 induces insulin-like growth factor-1 expression by a tumor necrosis factor-α-dependent mechanism in murine macrophages
47. Changes in procoagulant and fibrinolytic gene expression during bleomycin-induced lung injury in the mouse
48. Endogenous fibrinolytic system in chronic largevessel thromboembolic pulmonary hypertension
49. Polymerization of fibrinogen in murine bleomycin-induced lung injury
50. Coordinated induction of plasminogen activator inhibitor-1 (PAI-1) and inhibition of plasminogen activator gene expression by hypoxia promotes pulmonary vascular fibrin deposition
51. The c-mycregulated gene mrl encodes plasminogen activator inhibitor 1
52. Production of fibronectin by the human alveolar macrophage: Mechanism for the recruitment of fibroblasts to sites of tissue injury in interstitial lung diseases
53. Regulation, location and activity of plasminogen activator inhibitor 2 (PAI-2) in peripheral blood monocytes, macrophages and foam cells
54. Regulation of murine type 1 plasminogen activator inhibitor gene expression in vivo. Tissue specificity and induction by lipopolysaccharide, tumor necrosis factor-alpha, and transforming growth factor-beta
55. Participation of pulmonary alveolar epithelial cells in lung inflammation
56. Promotion and subsequent inhibition of plasminogen activation after administration of intravenous endotoxin to normal subjects
57. Amiloride selectively inhibits the urokinase-like plasminogen activator
58. Concomitant secretion of prourokinase and of a plasminogen activator-specific inhibitor by cultured human monocytes-macrophages
59. The plasminogen activator/plasmin system
60. Angiogenesis induced by degradation products of hyaluronic acid
61. The effect of hyaluronate and its oligosaccharides on endothelial cell proliferation and monolayer integrity
62. Plasminogen activator-specific inhibitors in mouse macrophages: In vivo and in vitro modulation of their synthesis and secretion